Top Markets
#1 DogBull DogBull +105.44%
#2 Siacoin Siacoin +49.01%
#3 ADO Protocol ADO Protocol +47.01%
#4 UnifAI Network UnifAI Network +43.78%
#5 MarsCoin MarsCoin +39.76%
#6 Magma Finance Magma Finance +32.17%
#7 Useless Coin Useless Coin +27.08%
#8 Ontology Gas Ontology Gas +18.64%
#9 Nockchain Nockchain +16.11%
#10 Apertum Apertum +14.70%
Coin of the day
DogBull DogBull
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Peringkat dalam Saham #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Harga Saham
$7.15
Kapitalisasi Pasar
$313.60M
Perubahan (1 hari)
-2.12%
Perubahan (1 tahun)
-84.14%
Negara
DE
Perdagangan Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategori

Healthcare
Pendapatan untuk Anbio Biotechnology Class A Ordinary Shares (NNNN)
Pendapatan pada Sep 2026 TTM: 0
Menurut laporan keuangan terbaru dari Anbio Biotechnology Class A Ordinary Shares, pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Anbio Biotechnology Class A Ordinary Shares dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH